Literature DB >> 32619130

Selective autophagy inhibition through disruption of the PIK3C3-containing complex I.

I Pavlinov1, M Salkovski1, L N Aldrich1.   

Abstract

The PIK3C3/VPS34-containing phosphatidylinositol 3-kinase (PtdIns3K) initiation complex (complex I) is necessary for macroautophagy/autophagy initiation and is comprised of PIK3R4/VPS15-PIK3C3/VPS34-BECN1-ATG14, while the endosomal trafficking complex (complex II) is necessary for vesicle trafficking and is comprised of PIK3R4/VPS15-PIK3C3/VPS34-BECN1-UVRAG. This composition difference was exploited to identify novel and specific autophagy inhibitors that disrupted the BECN1-ATG14 protein-protein interaction, without affecting vesicle trafficking. A cellular NanoBRET assay was implemented to identify these inhibitors, and one compound was able to successfully disrupt the BECN1-ATG14 interaction and inhibit autophagy, with limited impact on vesicle trafficking. These results reveal the first protein-protein interaction inhibitor targeting the autophagy initiation machinery and demonstrate the viability of targeting protein-protein interactions for the discovery of autophagy-specific modulators.

Entities:  

Keywords:  ATG14; BECN1; PIK3C3; autophagy; inhibitor; protein-protein interaction

Mesh:

Substances:

Year:  2020        PMID: 32619130      PMCID: PMC7469636          DOI: 10.1080/15548627.2020.1786268

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  1 in total

1.  Beclin 1-ATG14L Protein-Protein Interaction Inhibitor Selectively Inhibits Autophagy through Disruption of VPS34 Complex I.

Authors:  Ivan Pavlinov; Maryna Salkovski; Leslie N Aldrich
Journal:  J Am Chem Soc       Date:  2020-04-22       Impact factor: 15.419

  1 in total
  1 in total

Review 1.  The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer.

Authors:  Chien-An Chu; Yi-Wen Wang; Yi-Lin Chen; Hui-Wen Chen; Jing-Jing Chuang; Hong-Yi Chang; Chung-Liang Ho; Chen Chang; Nan-Haw Chow; Chung-Ta Lee
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.